Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
7-trioxo-4λ⁶-thia-1-azabicyclo[3
30(3):269-271
Smiles: O=C(NC1CC1)C1C=C(ON=1)C1=CC=CS1
PubMed PMID: 29108673
ZOL administration prevented osteolysis and significantly reduced the amount of OS-induced bone formation while has no effect on tumor burden at the primary site
Manidipine dihydrochloride D7545 7-trioxo-4λ⁶-thia-1-azabicyclo[3Manidipine dihydrochloride (CV 4093) is a dihydropyridine compound and a calcium channel blocker for Ca2+ current with IC50 of 2. 6 nM. IC50 value: 2. 6 nM Target: calcium channel Manidipine dihydrochloride is described to block T type Ca2+ channels specifically and is also described to have a high selectivity for the vasculature, presenting negligible cardiodepression as compared to other Ca2+ channel antagonists. Manidipine is also described to not
US$ 197.00
US$ 408.50
US$ 196.35